Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Viral Load Trends in HIV Patients

By HospiMedica staff writers
Posted on 11 Oct 2000
A study of the viral load record of more than 600,000 HIV patients showed that patients who were more frequently monitored had greater suppression of viral load. More...
This finding supports the belief that frequent blood monitoring and associated adjustments in therapy lead to more accurate intervention by treating physicians. The study was a collaborative effort among the University of North Carolina's Center for AIDS Research, the School of Public Health's biostatistical department, and Laboratory Corporation of America (LabCorp, Burlington, NC, USA).

LabCorp examined more than 600,000 test results and reported the following trends. The number of patients with undetectable viral load has risen dramatically, from 9% in 1996 to 44% by the end of 1999. Patients with lower initial viral loads were more likely to have suppressed viral loads. Viral rebound occurred in more than half the patients within a year. Male patients, older patients, or patients from the western part of the United States were more likely to have undetectable viral loads. Pediatric patients had the highest initial viral loads and were least likely to have suppressed viral loads.

LabCorp, the first U.S. laboratory to offer polymerase chain reaction (PCR) testing for early detection of HIV infection, now offers HIV genotyping and phenotyping for resistance testing. Specialists at the center's infectious disease laboratory focus on molecular diagnostics, using PCR and DNA probes to improve patient care by detecting, identifying, and quantifying pathogens.

The results from this study will provide HIV researchers and care providers with a clearer understanding of the factors associated with greater suppression of HIV viral load, said Dr. Hawazin Faruki, lead author of the study and LabCorp's vice president of operations
for the Center for Molecular Biology and Pathology.



Related Links:
Laboratory Corporation of America

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.